Hydrafinil

Specifciation:

This product is anticholinesterase drugs, a weaker anticholinesterase role, through the blood-brain barrier, so the role of the central nervous system is relatively strong. The obstruction of nerve and muscle conduction recovery, improve the various peripheral neuromuscular disorders paralysis. 

The treatment of a wide range of less toxic, more tolerable patients. Clinical mainly for the treatment of poliomyelitis (poliomyelitis) sequelae, muscle atrophy and myasthenia gravis. Can also be used for children with cerebral palsy, traumatic sensory dyskinesia, polyneuritis and spinal nerve root inflammation.

Analysis